Factors affecting risk of mortality in women with vaginal cancer

Obstetrics and Gynecology

Volumn 113, Issue 5, 2009, Pages 1038-1045

  Shah, Chirag A ^a   Goff, Barbara A ^b   Lowe, Kimberly ^b   Peters, William A ^b   Li, Christopher I ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER THERAPY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEALTH PROGRAM; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SQUAMOUS CELL CARCINOMA; VAGINA CANCER; CANCER REGISTRY; CANCER STAGING; CARCINOMA; COHORT ANALYSIS; DISEASE FREE SURVIVAL; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; SOCIOECONOMICS; SURVIVAL RATE; UNITED STATES; VAGINA TUMOR;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RISK FACTORS; SEER PROGRAM; SOCIOECONOMIC FACTORS; SURVIVAL RATE; UNITED STATES; VAGINAL NEOPLASMS; YOUNG ADULT;

EID: 66149101337     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31819fe844     Document Type: Article

References (24)

1. Graham JB, Meigs JV. Earlier detection of recurrent cancer of the uterine cervix by vaginal smear. Am J Obstet Gynecol 1952;64:908-14.
2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-30.
3. Creasman WT. Vaginal cancers. Curr Opin Obstet Gynecol 2005;17:71-6.
4. Creasman WT, Phillips JL, Menck HR. The National Cancer Data Base report on cancer of the vagina. Cancer 1998;83: 1033-40.
5. Herbst AL, Norusis MJ, Rosenow PJ, Welch WR, Scully RE. An analysis of 346 cases of clear cell adenocarcinoma of the vagina and cervix with emphasis on recurrence and survival. Gynecol Oncol 1979;7:111-22.
6. Herbst AL, Scully RE. Adenocarcinoma of the vagina in adolescence. A report of 7 cases including 6 clear-cell carcinomas (so-called mesonephromas). Cancer 1970;25:745-57.
7. Daling JR, Madeleine MM, Schwartz SM, Shera KA, Carter JJ, McKnight B, et al. A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 2002;84: 263-70.
8. Hellman K, Lundell M, Silfversward C, Nilsson B, Hellstrom AC, Frankendal B. Clinical and histopathologic factors related to prognosis in primary squamous cell carcinoma of the vagina. Int J Gynecol Cancer 2006;16:1201-11.
9. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute. NCI clinical announcement. Bethesda (MD): National Cancer Institute; 1999.
10. Omura GA; Gynecologic Oncology Group. Progress in gynecologic cancer research: the Gynecologic Oncology Group experience. Semin Oncol 2008;35:507-21.
11. Young JL Jr, Percy CL, Asire AJ, Berg JW, Cusano MM, Gloeckler LA, et al. Cancer incidence and mortality in the United States, 1973-77. Natl Cancer Inst Monogr 1981;(57): 1-187.
12. Cox DR. Regression model and life tables (with discussion). J R Stat Soc Ser B 1972;34:187-220.
13. Stock RG, Chen AS, Seski J. A 30-year experience in the management of primary carcinoma of the vagina: analysis of prognostic factors and treatment modalities. Gynecol Oncol 1995;56:45-52.
14. Otton GR, Nicklin JL, Dickie GJ, Niedetzky P, Tripcony L, Perrin LC, et al. Early-stage vaginal carcinoma-an analysis of 70 patients. Int J Gynecol Cancer 2004;14:304-10.
15. Wu X, Matanoski G, Chen VW, Saraiya M, Coughlin SS, King JB, et al. Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States. Cancer 2008;113 suppl:2873-82.
16. Khan MJ, Partridge EE, Wang SS, Schiffman M. Socioeconomic status and the risk of cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer 2005;104:61-70.
17. Davis KP, Stanhope CR, Garton GR, Atkinson EJ, O'Brien PC. Invasive vaginal carcinoma: analysis of early-stage disease. Gynecol Oncol 1991;42:131-6.
18. Rubin SC, Young J, Mikuta JJ. Squamous carcinoma of the vagina: treatment, complications, and long-term follow-up. Gynecol Oncol 1985;20:346-53.
19. Peters WA 3rd, Liu PY, Barrett RJ 2nd, Stock RJ, Monk BJ, Berek JS, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000;18:1606-13.
20. Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer [published erratum appears in N Engl J Med 1999;341:708]. N Engl J Med 1999;340:1144-53.
21. Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC Jr, et al Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999;17:1339-48.
22. Henson D, Tarone R. An epidemiologic study of cancer of the cervix, vagina, and vulva based on the Third National Cancer Survey in the United States. Am J Obstet Gynecol 1977;129: 525-32.
23. Grigsby PW. Vaginal cancer. Curr Treat Options Oncol 2002;3:125-30.
24. Dalrymple JL, Russel AH, Lew SW, Scudder SA, Leiserowitz GS, Kinney WK, et al. Chemoradiation for primary invasive squamous carcinoma of the vagina. Int J Gynecol Cancer 2004;14:110-7.